Zhujiang Hospital of Southern Medical University Guangdong
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
He, Yanjie
FUMANBA-03, NCT06464991: A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM

Recruiting
3
240
RoW
Equecabtagene Autoleucel Injection, FUCASO, Daratumumab, Pomalidomide, Bortezomib, Dexamethasone
Nanjing IASO Biotechnology Co., Ltd.
Multiple Myeloma
08/27
12/30
NCT05709093: A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Recruiting
3
552
RoW
Lemzoparlimab+Azacitidine (AZA), Azacitidine (AZA)
TJ Biopharma Co., Ltd.
Myelodysplastic Syndromes(MDS)
03/27
03/27
NCT04202003: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Checkmark Efficacy data from trial in combination with azacitidine for MDS
Sep 2022 - Sep 2022: Efficacy data from trial in combination with azacitidine for MDS
Checkmark Data from a study in combination with azacitidine for MDS at ESMO 2022
Sep 2022 - Sep 2022: Data from a study in combination with azacitidine for MDS at ESMO 2022
Completed
1/2
105
RoW
TJ011133
TJ Biopharma Co., Ltd.
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS)
12/23
12/23
NCT03407859: Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL

Recruiting
1
100
RoW
Sequential Treatment With different CART
Zhujiang Hospital, Nanfang Hospital, Southern Medical University
Therapy Related Leukemia
12/24
03/25
NCT03291444: CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Recruiting
1
30
RoW
Chimeric antigen receptor T cells, CAR-T, peptide specific dendritic cell, WT1 peptide specific dendritic cell, Eps8 peptide specific dendritic cell
Zhujiang Hospital, Shenzhen Geno-Immune Medical Institute, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), Myelodysplastic Syndromes
12/24
06/25

Download Options